Targeting 19S-Proteasome Deubiquitinase Rpn11/POH1/PSMD14 in Multiple Myeloma

被引：0
|
作者：
Song, Yan [1 ,2 ]
Ray, Arghya [1 ,2 ]
Sharma, Deepika [1 ,2 ]
Chauhan, Dharminder [1 ,2 ]
Anderson, Kenneth C. [1 ,3 ]
机构：
[1] Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, Boston, MA USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 13 条
  • [1] Deubiquitylating Enzyme Rpn11/POH1/PSMD14 As Therapeutic Target in Multiple Myeloma
    Song, Yan
    Ray, Arghya
    Das, Deepika Sharma
    Samur, Mehmet K.
    Carrasco, Ruben D.
    Munshi, Nikhil C.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2016, 128 (22)
  • [2] Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression
    Bustamante, Hianara A.
    Albornoz, Nicolas
    Morselli, Eugenia
    Soza, Andrea
    Burgos, Patricia V.
    CELLULAR SIGNALLING, 2023, 101
  • [3] POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells
    Spataro, Vito
    Buetti-Dinh, Antoine
    BRITISH JOURNAL OF CANCER, 2022, 127 (05) : 788 - 799
  • [4] POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells
    Vito Spataro
    Antoine Buetti-Dinh
    British Journal of Cancer, 2022, 127 : 788 - 799
  • [5] Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11
    Li, Jing
    Zhang, Yaru
    Dos Santos, Bruno Da Silva Sil
    Wang, Feng
    Ma, Yuyong
    Perez, Christian
    Yang, Yanling
    Peng, Junmin
    Cohen, Seth M.
    Chou, Tsui-Fen
    Hilton, Stephen T.
    Deshaies, Raymond J.
    CELL CHEMICAL BIOLOGY, 2018, 25 (11): : 1350 - +
  • [6] Therapeutically targeting 19S proteasome-associated subunit PSMD1/Rpn2 in multiple myeloma
    Du, Ting
    Wan, Xueping
    Ray, Arghya
    Pillai, Sindhu
    Carrasco, Ruben
    Munshi, Nikhil
    Chauhan, Dharminder
    Anderson, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S138 - S139
  • [7] Targeting Proteasome- Associated Ubiquitin Receptor PSMD4/Rpn10 in Multiple Myeloma
    Song, Yan
    Ray, Arghya
    Zhang, Guoqi
    Samur, Mehmet Kemal
    Munshi, Nikhil
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2017, 130
  • [8] Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle
    Luu, Anita K.
    Cadieux, Mia
    Wong, Mackenzie
    Macdonald, Rachel
    Jones, Robert
    Choi, Dongsic
    Oblak, Michelle
    Brisson, Brigitte
    Sauer, Scott
    Chafitz, James
    Warshawsky, David
    Wood, Geoffrey A.
    Viloria-Petit, Alicia M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [9] Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 in Multiple Myeloma
    Song, Yan
    Das, Deepika Sharma
    Ray, Arghya
    Ravillah, Durgadevi
    Munshi, Nikhil C.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [10] 26S Proteasome Non-Atpase Subunit 1, PSMD1/Rpn2, Is a Potential Therapeutic Target in Multiple Myeloma
    Du, Ting
    Wan, Xueping
    Ray, Arghya
    Yao, Yao
    Carrasco, Ruben D.
    Fulciniti, Mariateresa
    Munshi, Nikhil C.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2022, 140 : 8853 - 8854
12